1. Stocks
    2. /
  2. Mesoblast Limited (ASX: MSB)
    3. /

Mesoblast Limited (ASX: MSB) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Mesoblast Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Mesoblast Limited (ASX: MSB)
    Latest News

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Clinuvel, Mesoblast, Red Hill, and Resimac shares are sinking today

    | James Mickleboro

    These shares are having a tough time on Tuesday. But why?

    Read more »

    A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
    Healthcare Shares

    What's going on with the Mesoblast share price today?

    | James Mickleboro

    This biotech stock is heading south today despite the market roaring higher.

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Market News

    Top 10 most traded ASX shares and US stocks in May

    | Bronwyn Allen

    The most traded stock was an ASX 200 mega miner.

    Read more »

    a boy with sad eyes pulls the zip over his mouth and nose while doing up a large jacket where the collar stands up at head height.
    Share Market News

    Why these 3 top ASX 300 stocks dragged the benchmark lower this week

    | Bernd Struben

    Investors were hitting the sell button on these top ASX stocks over the week. But why?

    Read more »

    Scientists working in the laboratory and examining results.
    Healthcare Shares

    Insider still buying Mesoblast shares despite 230% rise this year: Should you buy?

    | James Mickleboro

    This high-flying share is still reporting insider buying. Should you buy too?

    Read more »

    Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
    Share Gainers

    If you invested $8,000 in Mesoblast shares at the beginning of 2024, guess how much you'd have now!

    | Bernd Struben

    Mesoblast shares have been soaring higher over the past six weeks. But why?

    Read more »

    Man puts hands in the air and cheers with head back while holding phone and coffee
    Broker Notes

    9 ASX All Ords shares elevated to 'strong buy' status in April

    | Bronwyn Allen

    Let's check them out.

    Read more »

    A young man clasps his hand to his head with a pained expression on his face and a laptop computer in front of him.
    Share Fallers

    Why Aeris Resources, Mesoblast, Pointsbet, and Worley shares are sinking today

    | James Mickleboro

    These shares are having a poor session on Tuesday. But why?

    Read more »

    Three guys in shirts and ties give the thumbs down.
    Healthcare Shares

    Why is the Mesoblast share price taking a dive on Tuesday?

    | James Mickleboro

    This high-flying share is under pressure today. But why?

    Read more »

    drug capsule opening up to reveal dollar signs signifying rising asx share price
    Share Gainers

    If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

    | Bernd Struben

    Mesoblast shares have been on a tear this past month. But why?

    Read more »

    Person handing out $50 notes, symbolising ex-dividend date.
    Share Market News

    Insiders are buying Mesoblast and these ASX shares

    | James Mickleboro

    Insiders seem to see value in these shares.

    Read more »

    A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
    Share Fallers

    Why Cardno, Mesoblast, Perseus, and Somnomed shares are dropping today

    | James Mickleboro

    These ASX shares are having a tough hump day. But why?

    Read more »

    Frequently Asked Questions

    No, Mesoblast does not pay shareholder dividends at this time.

    Yes, Mesoblast is listed on the ASX and the US Nasdaq under the ticker code NASDAQ: MESO.

    Mesoblast Ltd listed on the ASX on 16 December 2004.

    MSB ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Mesoblast Limited

    Mesoblast Ltd (ASX: MSB) is a clinical-stage biotechnology company. It develops and commercialises allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care.

    Its portfolio of Phase 3 product candidates includes its flagship remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD) as well as moderate to severe acute respiratory distress syndrome (ARDS). Its other candidates include REVASCOR® for advanced chronic heart failure and MPC-06-ID for chronic low back pain due to degenerative disc disease. These cell therapy candidates are towards the latter stages of their clinical trial pipelines. 

    Mesoblast has locations in Australia, the United States, and Singapore and is dual-listed on the ASX and the US Nasdaq (NASDAQ: MESO).

    Profile

    since

    Note